Director · Century Therapeutics, Inc. · Century Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
88.0K
Price
—
Executed
Dec 9, 2025
Disclosed
Dec 11, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 9 executedDec 11, 2025 disclosed
IPSC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Century Therapeutics, Inc. — Stock Option (right to buy)
Ticker
IPSC
Shares
88.0K
Price per share
$0
Execution date (reported)
Dec 9, 2025
Owned after transaction
88.0K shares
Days from execution to publication
2
What this establishes
Lee Han Myung filed this Form 4 reporting a grant or award of IPSC on Dec 9, 2025. It became public on Dec 11, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Lee Han Myungcik:0002100154
Issuer
Century Therapeutics, Inc.cik:0001850119
Revision history · 0
No field has changed since this record was first ingested.
